Study of erdafitinib versus chemotherapy (gemcitabine or mitomycin) for patients with high-risk non-muscle-invasive bladder cancer with FGFR mutations who failed BCG therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study on the Safety and Effectiveness of Garetosmab for Adults with Fibrodysplasia Ossificans Progressiva
Not recruiting
Investigated Drugs:
powered by
